Office for Nuclear Regulation

Curium Pharma UK Limited (Site) Transport – Inspection ID: 52219

Executive summary

Date(s) of inspection:

  • August 2023

Aim of inspection

The purpose of the inspection was to review compliance of Curium Pharma UK Limited’s arrangements for class 7 radioactive material for road transport, covering consignor duties.

Subject(s) of inspection

  • Transport (Non-nuclear) Appropriate management system – Rating: Green
  • Transport (Non-nuclear) Contingency plans in accordance with IRR Reg 13 – Rating: Green
  • Transport (Non-nuclear) Dangerous Goods Safety Advisor subsection 1.8.3 ADR – Rating: Green
  • Transport (Non-nuclear) Designation of Controlled or supervised areas Reg 17 IRR17 – Rating: Green
  • Transport (Non-nuclear) Emergency arrangements – Rating: Green
  • Transport (Non-nuclear) IRR17 Regulation 19 additional requirements – Rating: Green
  • Transport (Non-nuclear) Local rules Reg 18 IRR17 – Rating: Green
  • Transport (Non-nuclear) Radiation Protection Adviser Reg 14 IRR17 – Rating: Green
  • Transport (Non-nuclear) Radiation Risk Assessment Reg 8 of IRR 17 – Rating: Green
  • Transport (Non-nuclear) Training – Rating: Green
  • Transport (Non-nuclear) Transport documentation – Rating: Green

Key findings, inspector’s opinions and reasons for judgement made

The inspector reviewed a range of topics and identified a number of examples of Curium Pharma UK Limited meeting relevant good practice in reducing risk to levels that are ALARP. These included having transport Radiation Risk Assessments, Local Rules, IRR17 contingency plans, certificates of compliance for Type A transport packages used, transport documents, management systems, an annual Dangerous Goods Adviser Safety report and appointment of Safety Advisers and Radiation Protection Supervisors.

No non-compliances were identified but the inspector made some observations regarding improvements to Curium Pharma UK Limited’s arrangements in line with relevant good practice.


The inspection findings were presented to Curium Pharma UK Limited at the close of the inspection.

I judged an overall inspection rating of ‘Green – no formal action’ was appropriate for this inspection.

No non-compliances were identified but the inspector made some observations regarding improvements to Curium Pharma UK Limited’s arrangements in line with relevant good practice.